ACADIA Pharmaceuticals Inc. (ACAD)
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s disease psychosis, with additional pipeline candidates targeting neurological conditions. Chart
Checkpoint Therapeutics, Inc. (CKPT)
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing immuno-oncology and targeted therapies for cancer treatment. Its pipeline includes checkpoint inhibitors and small-molecule drugs designed to enhance anti-tumor response. Chart
Supernus Pharmaceuticals, Inc. (SUPN)
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on the development and commercialization of treatments for central nervous system disorders. Its portfolio includes therapies for epilepsy, ADHD, and migraines. Chart